Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

806
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
806
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

899
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
899
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mast cells promote pathology and susceptibility in tuberculosis.

eLife·2026
Same author

Targeting the lung innate pathways during tuberculosis can improve vaccine-induced protection via Th17 responses in diversity outbred mice.

mBio·2026
Same author

Therapeutic remodeling of the tuberculosis granuloma with 1-methyl-D-tryptophan enhances CD8<sup>+</sup> T cell-macrophage interactions.

bioRxiv : the preprint server for biology·2025
Same author

Concurrent TB and HIV therapies control TB reactivation during co-infection but not chronic immune activation.

Nature communications·2025
Same author

Single dose alum adjuvanted RBD protein vaccine provides protection against homologous challenge with SARS-CoV-2 Washington strain and heterologous rechallenge with Delta and Omicron BA.5 variants in K18 hACE2 mouse model.

bioRxiv : the preprint server for biology·2025
Same author

Development and preclinical evaluation of next-generation ΔsigH-based live candidate vaccines.

JCI insight·2025
Same journal

Host membranes provide hidden gateways for 'accidental pathogens'.

Trends in microbiology·2026
Same journal

Structural inequalities in global antimicrobial resistance governance.

Trends in microbiology·2026
Same journal

Environmental microbes as modulators of plant volatile landscapes: Implications for plant-insect chemical communication.

Trends in microbiology·2026
Same journal

Beyond AMGs: Phage-encoded transcription and sigma factors as understudied virocell reprogramming tools.

Trends in microbiology·2026
Same journal

Cronobacter spp.

Trends in microbiology·2026
Same journal

Anaerobic lignin deconstruction: A game changer for lignocellulosic biorefineries.

Trends in microbiology·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.8K

Type I interferons in tuberculosis pathogenesis and prevention.

Caden W Munson1, Deepak Kaushal1

  • 1Host-Pathogen Interactions Program, Texas Biomedical Research Institute, San Antonio, TX, USA; Department of Molecular Microbiology and Immunology, The University of Texas at San Antonio (UTSA), San Antonio, TX, USA.

Trends in Microbiology
|November 29, 2025
PubMed
Summary
This summary is machine-generated.

Type I interferons (IFNs) show dual roles in tuberculosis (TB) infection, acting as both pathological and protective. Understanding Type I IFN signaling is crucial for developing effective TB vaccines and treatments.

Keywords:
Type I IFNgranulomanonhuman primatestuberculosis

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.4K

Related Experiment Videos

Last Updated: Jan 9, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.8K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.4K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Tuberculosis (TB) poses a significant global health challenge with varied patient outcomes.
  • The precise role of Type I interferons (IFNs) in TB pathogenesis remains incompletely understood.
  • Early immune responses, particularly Type I IFN signaling, are critical in determining TB infection trajectory.

Purpose of the Study:

  • To review the current knowledge on the function of Type I IFNs during Mycobacterium tuberculosis (Mtb) infection.
  • To explore the dual role of Type I IFNs in TB, considering both pathological and protective aspects.
  • To discuss the implications of Type I and Type II IFN signaling crosstalk in TB disease progression.

Main Methods:

  • Literature review of existing research on Type I IFNs in TB.
  • Analysis of studies investigating Mtb-host interactions and immune responses.
  • Exploration of data related to TB vaccination and adjunctive therapies involving IFNs.

Main Results:

  • Type I IFNs are early indicators of progressive Mtb infection.
  • Evidence suggests Type I IFNs can be detrimental but also offer protection in specific contexts like vaccination.
  • The interplay between Type I and Type II IFN signaling pathways is a key factor in TB outcomes.

Conclusions:

  • Type I IFNs exhibit a complex, context-dependent role in TB.
  • The proposed 'IFN type switching model' offers a framework to understand the duality of Type I IFN functions in TB.
  • Further research into Type I IFN signaling is essential for advancing TB control strategies.